Incidence and course of dementia in people with Down's syndrome: findings from a population-based study.
about
On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndromeRivastigmine for dementia in people with Down syndromeMemantine for dementia in people with Down syndromeGalantamine for dementia in people with Down syndromeDonepezil for dementia in people with Down syndromeIntracerebral haemorrhage in Down syndrome: protected or predisposed?A genetic cause of Alzheimer disease: mechanistic insights from Down syndromeThe LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndromeParticipatory research to design a novel telehealth system to support the night-time needs of people with dementia: NOCTURNAL.Adults with Down's syndrome: the prevalence of complications and health care in the community.Alzheimer's Disease in Down Syndrome.Differentiating Aging Among Adults With Down Syndrome and Comorbid Dementia or PsychopathologyBehavior and adaptive functioning in adolescents with Down syndrome: specifying targets for intervention.Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial.Bereavement and behavioral changes as risk factors for cognitive decline in adults with Down syndrome.Age-related changes of adaptive and neuropsychological features in persons with Down Syndrome.Prospective and episodic memory in relation to hippocampal volume in adults with spina bifida myelomeningocele.Down syndrome--recent progress and future prospects."Down syndrome: an insight of the disease"Cholesterol level, statin use and Alzheimer's disease in adults with Down syndrome.Developmental trajectories in adolescents and adults with autism: the case of daily living skills.Aging and down syndromeAcute neuropsychiatric disorders in adolescents and young adults with Down syndrome: Japanese case reports.Semantic Verbal Fluency Pattern, Dementia Rating Scores and Adaptive Behavior Correlate With Plasma Aβ42 Concentrations in Down Syndrome Young AdultsThe effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B.Hypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis.Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21.Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanismsConsensus guidelines for primary health care of adults with developmental disabilities.Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trialDevelopmental regression, depression, and psychosocial stress in an adolescent with Down syndrome.Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.Frontal white matter integrity in adults with Down syndrome with and without dementia.The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies.People with intellectual disability: what do we know about adulthood and life expectancy?Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis.Atypical aging in Down syndrome.Dementia in people with intellectual disability: insights and challenges in epidemiological research with an at-risk population.Stem and progenitor cell dysfunction in human trisomies.Reporting of health problems and pain by adults with an intellectual disability and by their carers.
P2860
Q22241936-CFE1BAA8-565E-4143-A165-39662E04D5B0Q22252965-ED00B206-0817-4242-B6AD-45DF14F99E46Q22252966-DA405B0B-50DC-4169-A832-84FA7D0F3711Q22252968-81AB2A94-871F-4A08-970A-AB1139F00753Q24241803-3223D84C-44CB-4A2D-BDE6-3D8B68980F15Q26745369-30FFD5E0-D4D8-4665-A395-B53208502897Q26798983-1E206735-30C6-4172-A241-5DB5C1D79FB3Q28585473-4034903C-C4F6-4A1F-BB83-1DF0FD2F4C0AQ30356373-7FF12A9D-D9DB-4DD2-9CFA-DBFF4B0EE0BEQ30499159-F0AF7E66-4698-4793-9133-12411338E1C8Q30857550-435A25FB-9A6A-47ED-B4BC-C7A642146F92Q33564720-A337B6E4-CB3D-4896-8270-E2274B294842Q33714164-AC74E65A-6E29-4C19-B537-42C9D7C44162Q33770940-7150BDD6-8C8A-496E-B593-AB857554A624Q34555373-37625084-03A3-4F8D-AD6A-F0969773F2D8Q34566084-16B9080B-7EF9-499E-B6F0-6C377A1BF073Q34859772-580F7CAE-7D38-4F18-AF17-EB7BC32AE2A7Q34964947-8AD4CEB1-7CAD-43BC-9D53-5A06B98290B6Q35730155-AF5D7AF2-399F-4146-AB95-89B4369A5E74Q35842893-98408A4D-7F3E-4022-AD0A-D5B9F298CDF8Q35992651-C021FF44-CA7A-4E4C-90E6-CB3C875BBFADQ36104322-3B73E25E-CB57-49E7-8291-67030F337A41Q36148727-8BE9D3B7-7980-4E13-8788-366C9F8741D3Q36290131-6B9CAF9F-7EE3-4302-BAE8-4DAD3B5D8AB7Q36366578-194BA4B3-93D7-4354-89A9-9A1AF37BC9AAQ36637693-53BA0625-F1C3-45B5-B6B3-D827A594771AQ36681400-E108F54C-13DB-4344-B1C8-F1E861060FE9Q36712099-EE920F42-7658-4AA8-83BB-943B26FE7292Q36728611-46FC75DB-6B99-424E-AD98-DEE340F05E58Q37139026-DFF49924-EB4C-49A2-B5A5-7B5C53CBC0FAQ37449251-064917DE-0FEC-4B81-969E-2D2F4B370C4FQ37503442-0BB57A26-E37F-48A6-95D6-3908A366694CQ37712416-F80A7699-35AE-43E6-B7C8-453D9D583366Q37712705-898C9B77-184A-4A00-9C78-07042818F699Q38129320-3EBD6184-25DF-4323-A320-327B7E410C65Q38129323-49822D3F-06F3-4C94-B7C4-77568A6BC9C0Q38129325-485DD105-9B2C-4A94-BC60-03EF0C5EEBFBQ38178376-B0B41E2F-D8F3-4E81-8969-5EC3701837F3Q38292512-C19FDE01-1A07-4AE7-A39B-CB125F3BFD76Q38433444-4FB21523-821B-4B08-A654-D54E932ACCEC
P2860
Incidence and course of dementia in people with Down's syndrome: findings from a population-based study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Incidence and course of dement ...... from a population-based study.
@en
Incidence and course of dement ...... from a population-based study.
@nl
type
label
Incidence and course of dement ...... from a population-based study.
@en
Incidence and course of dement ...... from a population-based study.
@nl
prefLabel
Incidence and course of dement ...... from a population-based study.
@en
Incidence and course of dement ...... from a population-based study.
@nl
P2093
P2860
P1476
Incidence and course of dement ...... from a population-based study.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2788.2000.00263.X
P478
44 ( Pt 2)
P577
2000-04-01T00:00:00Z